Journals / Türk Yoğun Bakım Dergisi / 2019 / Cilt: 17 - Sayı: 3

The Relationship Between the Level of Inflammation Biomarkers at Admission to the Intensive Care Unit and the Duration of Acute Brain Dysfunction in Sepsis Patients

Yoğun Bakım Ünitesine Girişte Enflamasyon Biyobelirteçlerinin Düzeyi ile Sepsis Hastalarında Akut Beyin Disfonksiyonunun Süresi Arasındaki İlişki

Pages
138–145
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further investigations are needed on the inflammatory mechanisms of acute brain dysfunction in sepsis patients.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Acute brain dysfunction (delirium and coma) occurs frequently in critically ill patients and is associated with increased morbidity and mortality.
📊
Key Findings & Data:Results: A total of 79 sepsis patients (45 men, 34 women; 53.4±10.6 years) with acute brain dysfunction were enrolled.
💡
Conclusion & Impact:Further investigations are needed on the inflammatory mechanisms of acute brain dysfunction in sepsis patients.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Acute brain dysfunction (delirium and coma) occurs frequently in critically ill patients and is associated with increased morbidity and mortality. Septic patients with brain dysfunction may differ from the general critically ill population. The aim of this investigation was to study the relationship between systemic inflammation markers and duration of acute brain dysfunction in sepsis patients. Materials and Methods: This study was a prospective, single-center, observational study of consecutive patients admitted with sepsis to the medical and surgical intensive care unit (ICU). Patients were assessed for coma and delirium with the Richmond Agitation-Sedation Scale and Confusion Assessment Method for the ICU. Plasma levels of procalcitonin and C-reactive protein (CRP) were measured on the day of ICU admission. Linear regression analysis was performed to determine the relationship between biomarkers and delirium/coma-free days. Results: A total of 79 sepsis patients (45 men, 34 women; 53.4±10.6 years) with acute brain dysfunction were enrolled. Higher procalcitonin levels were associated with fewer delirium/comafree days (p=0.04, Correlation confidence: -0,343, R2= 0,12), whereas higher CRP levels were not correlated. Conclusion: In our present study, procalcitonin measured on admission to ICU predicted prolonged periods of acute brain dysfunction. Further investigations are needed on the inflammatory mechanisms of acute brain dysfunction in sepsis patients.

Özet

Amaç: Akut beyin disfonksiyonu (deliryum ve koma) kritik hastalarda sıklıkla görülür ve morbidite ve mortalite artışı ile ilişkilidir. Beyin disfonksiyonu olan sepsis hastaları genel kritik hasta popülasyonundan farklı olabilir. Bu araştırmanın amacı, sepsis hastalarında sistemik enflamasyon biyobelirteçleri ile akut beyin disfonksiyonunun süresi arasındaki ilişkiyi incelemektir. Gereç ve Yöntem: Medikal ve cerrahi yoğun bakım ünitesine sepsis ile başvuran hastaların prospektif, tek merkezli, gözlemsel çalışmasıdır. Richmond Ajitasyon-Sedasyon Skalası ve Yoğun Bakım Ünitesinde Konfüzyon Değerlendirme Yöntemi ile koma ve deliryum için hastalar değerlendirildi. Yoğun bakıma girişte prokalsitonin ve C-reaktif protein (CRP) plazma düzeyleri ölçüldü. Biyobelirteçler ve deliryum/koma olmayan gün sayısı arasındaki ilişkileri belirlemek için doğrusal regresyon analizi yapıldı. Bulgular: Akut beyin disfonksiyonu olan toplam 79 sepsis hastası (45 erkek, 34 kadın; 53,4±10,6 yaş) kaydedildi. Daha yüksek prokalsitonin düzeyleri deliryum/koma olmayan gün sayısı ile ilişkiliydi [p=0,04, güven aralığı: -0,343, R2: 0,12], buna karşılık CRP düzeyleri ile korelasyon yoktu. Sonuç: Bu çalışmamızda, yoğun bakım ünitesine girişte ölçülen prokalsitonin akut beyin disfonksiyonunun daha uzun sürmesini öngörmektedir. Sepsis hastalarında akut beyin disfonksiyonunun enflamatuvar mekanizmaları daha ileri araştırmalarla incelenmelidir.

🔖

Cite This Article

ORHUN, G., ALİ, A., ALAY, G., TUNA, V., ÇELİKSOY, E., ESEN, F. (2019). The Relationship Between the Level of Inflammation Biomarkers at Admission to the Intensive Care Unit and the Duration of Acute Brain Dysfunction in Sepsis Patients. Türk Yoğun Bakım Dergisi, Cilt: 17 - Sayı: 3, 138–145. https://ajindex.com/articles/327711

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Iacobone E, Bailly-Salin J, Polito A, Friedman D, Stevens RD, Sharshar T. Sepsis-associated encephalopathy and its differential diagnosis. Crit Care Med 2009;37(10 Suppl):331-6
  2. Eidelman LA, Putterman D, Putterman C, Sprung CL. The spectrum of septic encephalopathy. Definitions, etiologies, and mortalities. JAMA 1996;275:470-3
  3. Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 2004;291:1753-62
  4. Sharshar T, Hopkinson NS, Orlikowski D, Annane D. Science review: The brain in sepsis--culprit and victim. Crit Care 2005;9:37-44
  5. Sonneville R, Verdonk F, Rauturier C, Klein IF, Wolff M, Annane D, et al. Understanding brain dysfunction in sepsis. Ann Intensive Care 2013;3:15
  6. Gofton TE, Young GB. Sepsis-associated encephalopathy. Nat Rev Neurol 2012:557-66
  7. Hopkins RO, Jackson JC. Short- and longterm cognitive outcomes in intensive care unit survivors. Clin Chest Med 2009;30:143-53
  8. Girard TD, Jackson JC, Pandharipande PP, Pun BT, Thompson JL, Shintani AK, et al. Delirium as a predictor of long-term cognitive impairment in survivors of critical illness. Crit Care Med 2010;38:1513-20
  9. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 2010;304:1787-94
  10. Hopkins RO, Weaver LK, Collingridge D, Parkinson RB, Chan KJ, Orme JF Jr. TwoYear Cognitive, Emotional, and Qualityof-Life Outcomes in Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2005;171:340-7
  11. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA 2007;298:2644-53. 12. van den Boogaard M, Kox M, Quinn KL, van Achterberg T, van der Hoeven JG, Schoonhoven L, et al. Biomarkers associated with delirium in critically ill patients and their relation with longterm subjective cognitive dysfunction; indications for different pathways governing delirium in inflamed and noninflamed patients. Crit Care 2011;15:297
  12. Ritter C, Tomasi CD, Dal-Pizzol F, Pinto BB, Dyson A, de Miranda AS, et al. Inflammation biomarkers and delirium in critically ill patients. Crit Care 2014;18:106
  13. Orhun G, Tüzün E, Özcan PE, Ulusoy C, Yildirim E, Küçükerden M, et al. Association Between Inflammatory Ma